More Than 1,300 International Experts in Montreal Will Address a Promising Therapeutic Avenue: Neuromodulation

The news briefing, led by the president of the Canadian Neuromodulation Society, Michel Prud’Homme, MD, PhD, a neurosurgeon at CHU de Québec – Laval University, immediately precedes a free public lecture on neuromodulation therapies. This free public lecture is a local satellite event of the International Neuromodulation Society (INS) 12th World Congress, and has been organized by the Canadian Neuromodulation Society, an INS chapter.

Neuromodulation therapy is rapidly developing and aiding patients who have a number of chronic conditions. Among the conditions to be presented at the public lecture on June 6 are chronic pain, neurodegenerative conditions such as Parkinson’s disease, and bladder motility disorders. These and other conditions will be discussed during preconferences and the scientific program of the International Neuromodulation Society 12th World Congress from June 6 – 11, 2015.

Immediately after the news briefing, the Canadian chapter’s free public lecture on Saturday, June 6, from 12 – 4:40 p.m. is open to patients, family members, interested members of the public, members of the news media, and professionals. It will feature experts and patients, with question-and-answer sessions moderated by journalist Bernard Derome. What: Canadian Neuromodulation Society News BriefingWhen: 11:00 – 11:45 a.m. June 6, 2015

Please request complimentary press credentials to the June 6th news briefing, or main scientific congress June 6 – 11, at:http://www.neuromodulation.com/12th-world-congress-news-centerAbout the International Neuromodulation SocietyThe International Neuromodulation Society (INS) is a nonprofit medical society that unites clinicians, scientists and engineers to share scientific knowledge about all aspects of neuromodulation in order to encourage best medical practice. Founded in 1989 and based in San Francisco, CA, the INS presents up-to-date information about the full breadth of neuromodulation therapies through an interactive website at http://www.neuromodulation.com, chapter scientific meetings, the MEDLINE-indexed journal Neuromodulation: Technology at the Neural Interface, and its biennial world congress.